Orin Hirschman
@Aigh Capital Management Llc
Latest period2024 - Q3ReportedManaged Assets$354.554MTotal holdings39
Assets growth rate10.45%Assets growth rate (2-Q avg)3.43%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Aigh Capital Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 39 positions.
Assets under management
The assets under management (AUM) of Aigh Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 354.554M in assets, with a quarterly growth rate of 10.45% and a 2-quarter average growth rate of 3.43%. The portfolio is managed by Orin Hirschman, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
CLRBCellectar Biosciences Inc
| 1.93% | $6.842M 3.197M shares@ $2.15 avg price | Increased 5.31% |
TARSTarsus Pharmaceuticals Inc
| 1.9% | $6.723M 204,413 shares@ $32.9 avg price | New Position |
TELATela Bio Inc
| 1.77% | $6.248M 2.469M shares@ $2.53 avg price | Increased 49.06% |
XERSXeris Biopharma Holdings Inc
| 1.76% | $6.229M 2.186M shares@ $2.86 avg price | New Position |
BKTIBk Technologies Corporation
| 1.74% | $6.156M 282,772 shares@ $21.78 avg price | |
IPWRIdeal Pwr Inc
| 1.62% | $5.74M 700,000 shares@ $8.2 avg price | |
ELVAElectrovaya Inc
| 1.62% | $5.716M 2.448M shares@ $2.34 avg price | Decreased -4.96% |
LPTHLightpath Technologies Inc
| 1.44% | $5.102M 3.724M shares@ $1.37 avg price | |
THTXTheratechnologies Inc
| 1.31% | $4.61M 3.725M shares@ $1.24 avg price | |
EGRXEagle Pharmaceuticals Inc
| 1.28% | $4.519M 1.212M shares@ $3.73 avg price |